U.S., Dec. 17 -- ClinicalTrials.gov registry received information related to the study (NCT07285213) titled 'Prevention of Recurrent C. Difficile Infection Study With AZD5148 Monoclonal Antibody' on Nov. 20.
Brief Summary: The purpose of this study is to evaluate the efficacy and safety of AZD5148 for prevention of recurrence of Clostridioides difficile infection in Individuals 18 years of age and above.
Study Start Date: Dec. 19
Study Type: INTERVENTIONAL
Condition:
Clostridioides Difficile Infection
Intervention:
DRUG: AZD5148
Participants will receive a single dose A of AZD5148 administered via either intramuscular injection or intravenous push.
OTHER: Placebo
Participants will receive a single dose of placebo (0.9% (w/v) sodiu...